You are here

Compounded medicines and good manufacturing practice (GMP)

Guide to the interpretation of the PIC/S Guide to GMP for compounded medicinal products

29 May 2017

Book pagination

The following guidance is provided to assist in the interpretation of the PIC/S GMP requirements when manufacturing compounded medicines. Clause numbers referenced are from PIC/S “Guide to GMP for Medicinal Products” PE 009-8 15 Jan 2009.


The purpose of this document is to clarify the PIC/S Guide to GMP for Medicinal Products PE-009 requirements for the manufacture of extemporaneously compounded medicines. This document is only applicable to licensable manufacturers, although may be used as guidance for pharmacists performing compounding that are considered exempt from licensing under the Therapeutic Goods Regulations 1990.

This document has been developed in relation to the PIC/S Guide of GMP for Medicinal Products PE-009-8 15 January 2009, following consultation with stakeholders.


Compounding: The preparation, mixing, assembling, altering, packaging, and labelling of a medicines, medicine-delivery device or device in accordance with a doctor’s prescription, or initiative based on the doctor/patient/pharmacist/compounder relationship in the course of professional practice. Compounding includes the following:

  • Preparation of medicine dosage forms for both human and animal patients
  • Preparation of medicines or devices in anticipation of prescription medicine orders based on routine, regularly observed prescribing patterns
  • Reconstitution or manipulation of commercial products that may require the addition of one or more ingredients
  • Preparation of medicines or devices for the purposes of, or as an incident or, research (clinical or academic), teaching, or chemical analysis
  • Preparation of medicines and devices for a doctor’s premises use where permitted by Commonwealth and State law.
  • Synthesis of a radiopharmaceutical medicine, e.g. radiolabelling of a ligand with a radioisotope.

Dispensing: The manipulation of a commercially available product, in accordance with the manufacturer’s instructions, in order to produce a medicines in a ‘ready to administer’ form. Examples include reconstitution of oral antibiotic mixtures and aseptic transfer to a sterile device. (Where a manufacturer’s instructions are not followed, for example a different diluent is used, this is considered compounding.)

Interpretation of the basic GMP requirements

Where a clause number or an Annex is not listed, there is no specific interpretation provided for manufacture of extemporaneously compounded products.

Please note:

Compounded and dispensed medicines are not exempt from meeting the quality standards set out in the Therapeutic Goods Act 1989.

Book pagination